Catalyst Wire Dossier Catalyst Wire Dossier

OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES

HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN · GE Healthcare Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES, covering 2007-11-08 to 2025-05-09. Get the full timeline:

Most recent: FDA Approved: OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES — Supplemental Application (GE Healthcare Inc.)

See pricing